Sign In
Section Navigation
Common TitleACTG 347
Official Title A Randomized, Double-Blind, Phase II Study of Amprenavir (141W94/VX-478) Monotherapy vs. Amprenavir (141W94/VX-478) Plus ZDV Plus 3TC in HIV Infected Individuals
Phase Phase II
ClinicalTrials.gov NCT00001085
Categories Treatment-ExperiencedMonotherapy
Funding
Non-IndustryNational Institute of Allergy and Infectious Diseases (NIAID)
References
  • Murphy RL, Gulick RM, DeGruttola V, et al. Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team. J Infect Dis. 1999;179:808-16.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.